Metformin use and long-term risk of benign prostatic hyperplasia: a population-based cohort studyMette Nørgaard, Bianka Darvalics, Reimar Wernich Thomsen
22 December 2020
What is the risk of prostate cancer mortality following negative systematic TRUS-guided biopsies? A systematic reviewSandra Miriam Kawa, Signe Benzon Larsen, John Thomas Helgstrand, Peter Iversen, Klaus Brasso, Martin Andreas Røder
18 December 2020
Detailing sexual outcomes after treatment of localised prostate cancer with focal therapy using various energy sources: protocol for a mixed-methods studyGaelle Fiard, Daniel Kelly, Tet Yap, Mark Emberton
15 December 2020
Design and development of the Pediatric Urology Recovery After Surgery Endeavor (PURSUE) multicentre pilot and exploratory studyKyle O Rove, Andrew C Strine, Duncan T Wilcox, Gino J Vricella, Timothy P Welch, Brian VanderBrink, David I Chu, Rajeev Chaudhry, Rebecca S Zee, Megan A Brockel, , PURSUE Study group, Douglas E. Coplen, Paul F. Austin, Erica J. TraxelSee the full list of authors
23 November 2020
Assessment of a patient-reported outcome measure in men with prostate cancer who had radical surgery: a Rasch analysisEva Protopapa, Jan van der Meulen, Caroline M Moore, Sarah C Smith
14 November 2020
Assessing the safety and feasibility of neoadjuvant hormone and radiation therapy followed by robot-assisted radical prostatectomy for treating locally advanced prostate cancer: protocol for an open-label, dose-escalation, single-centre, phase I clinical trialYu-Tian Xiao, Xianzhi Zhao, Yifan Chang, Xiaojun Lu, Ye Wang, Huojun Zhang, Shancheng Ren
3 November 2020
Histopathological features of prostate cancer conspicuity on multiparametric MRI: protocol for a systematic review and meta-analysisJoseph M Norris, Lina M Carmona Echeverria, Benjamin S Simpson, Rhys Ball, Alex Freeman, Daniel Kelly, Alex Kirkham, Hayley C Whitaker, Mark Emberton
22 October 2020
Cohort profile: the Alberta Prostate Cancer Research Initiative (APCaRI) Registry and Biorepository facilitates technology translation to the clinic through the use of linked, longitudinal clinical and patient-reported data and biospecimens from men in Alberta, CanadaCatalina Vasquez, Michael Kolinsky, Rume Djebah, Maxwell Uhlich, Bryan Donnelly, Adrian S Fairey, Eric Hyndman, Nawaid Usmani, Jackson Wu, Peter Venner, Dean Ruether, Gerald Todd, Michael Chetner, R Trafford Crump, Perrin H BeattySee the full list of authors
16 October 2020
Efficacy of neoadjuvant atezolizumab treatment in patients with advanced urothelial bladder cancer according to the BASQ classification: a study protocol for an open-label, two-cohort, phase II trialHyeong Dong Yuk, Chang Wook Jeong, Cheol Kwak, Hyeon Kim, Kyung Chul Moon, Ja Hyeon Ku
15 October 2020
Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trialJulia Wade, Jenny Donovan, Athene Lane, Michael Davis, Eleanor Walsh, David Neal, Emma Turner, Richard Martin, Chris Metcalfe, Tim Peters, Freddie Hamdy, Roger Kockelbergh, James Catto, Alan Paul, Peter HoldingSee the full list of authors
9 September 2020
